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Abstract
Muscle cell apoptosis accompanies normal muscle development and regeneration, as well as
degenerative diseases and aging. C2C12 murine myoblast cells represent a common model to
study muscle differentiation. Though it was already shown that myogenic differentiation of C2C12
cells is accompanied by enhanced apoptosis in a fraction of cells, either the cell population
sensitive to apoptosis or regulatory mechanisms for the apoptotic response are unclear so far. In
the current study we characterize apoptotic phenotypes of different types of C2C12 cells at all
stages of differentiation, and report here that myotubes of differentiated C2C12 cells with low
levels of anti-apoptotic Bcl-2 expression are particularly vulnerable to apoptosis even though they
are displaying low levels of pro-apoptotic proteins Bax, Bak and Bad. In contrast, reserve cells
exhibit higher levels of Bcl-2 and high resistance to apoptosis. The transfection of proliferating
myoblasts with Bcl-2 prior to differentiation did not protect against spontaneous apoptosis
accompanying differentiation of C2C12 cell but led to Bcl-2 overexpression in myotubes and to
significant protection from apoptotic cell loss caused by exposure to hydrogen peroxide. Overall,
our data advocate for a Bcl-2-dependent mechanism of apoptosis in differentiated muscle cells.
However, downstream processes for spontaneous and hydrogen peroxide induced apoptosis are
not completely similar. Apoptosis in differentiating myoblasts and myotubes is regulated not
through interaction of Bcl-2 with pro-apoptotic Bcl-2 family proteins such as Bax, Bak, and Bad.
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INTRODUCTION
Muscle cell apoptosis accompanies normal muscle development as well as degenerative
diseases and biological aging [1-5]. While the role of apoptosis in muscle degradation is not
fully understood, it is known that stress conditions, such as oxidative stress [6], denervation
[7], mitochondrial dysfunction [8, 9], and accumulation of advanced glycation endproducts
[10, 11] enhance muscle cell apoptosis, which may contribute to skeletal muscle atrophy and
sarcopenia. Skeletal muscle is very adaptive to stress due to a remarkable regenerative
capability attributed to the growth and differentiation of satellite cells. Myogenic
differentiation is a complex multi-step process controlled by myogenic transcription factors
and also accompanied by the activation of the caspase family of proteases, which play a
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central role in the execution of apoptosis [12]. As a result of caspase activation during
myogenic differentiation, a fraction of cells undergoes apoptosis rather than forms myotubes
or reserve cells; in cell culture, such cells detach from the plates and display an apoptotic
phenotype [13, 14].
The C2C12 cell line derived from murine skeletal muscle cells represents a common model
to study muscle regeneration and differentiation induced by partial serum withdrawal. It was
demonstrated that apoptosis is a distinctive part of the differentiation; in particular,
caspase-3, caspase-9 and endoplasmic reticulum (ER) stress-specific caspase-12 are required
for activation of differentiation and subsequent cell fusion to form myotubes [13, 15, 16].
Some fractions of C2C12 cells may undergo apoptosis, or terminal differentiation to form
myotubes, or reversibly exit the cell cycle to enter a quiescent state, thus forming reserve
cells, which show many characteristics of muscle satellite cells. Given that muscle tissue
represents a heterogeneous system, a question arises which types of cells are subject to
apoptotic elimination in muscle tissue and which mechanisms are involved in the differential
sensitivity of cells to apoptosis.
A number of studies demonstrate the potential importance of Bcl-2 family proteins in
muscle apoptosis. For instance, muscle-specific overexpression of Bcl-2 in mouse models of
laminin α2-deficient dystrophy [4] and oculopharyngeal muscular dystrophy ameliorates
disease [17], but not in a dystrophin-deficient model. Exercise training prevents the
apoptosis of skeletal muscle, possibly through an increase of the Bcl-2/Bax ratio [18].
Biological aging increases the predisposition of skeletal muscle-derived satellite cells to
apoptosis that correlates with a lower amount of Bcl-2 in old relative to young adult animals
[19]. An age-associated increase of Bax and decrease of Bcl-2 levels was suggested as a
putative mechanism of apoptosis in aging tissue [7, 20]. However, most of these studies
were designed to determine the effect of Bcl-2 in animal models of muscle dystrophies and
did not target the types of muscle cells and the underlying mechanisms of apoptosis.
The anti-apoptotic protein Bcl-2 can bind the pro-apoptotic protein Bax, inhibiting its
homodimerization, which otherwise would lead to the induction of cytochrome c release
from mitochondria, followed by caspase activation [21, 22]. Bcl-2 can also regulate
intracellular Ca2+ levels, where Ca2+ released from the ER and taken up by the mitochondria
can activate Ca2+-dependent caspases to execute apoptosis [23-27]. In fact, perturbed Ca2+
homoeostasis has been recognized as one factor responsible for muscle degeneration [28,
29]. SERCA2B represents a “housekeeping” isoform of the Ca2+ pump, which is responsible
for Ca2+ uptake into the ER in various types of cells and, thus, implicated in the regulation
of multiple Ca2+-dependent processes such as protein folding, ATP-production in the
mitochondria, and apoptosis [30, 31]. Unfortunately, data on the levels of SERCA2B in
muscle tissue or differentiating C2C12 cells are not available. This is especially important in
view of a potential role of Bcl-2 with regard to Ca2+ homeostasis. For example, Bcl-2
overexpression prevented Ca2+ overload and inhibited apoptosis in dystrophic myotubes
[32], and in vitro studies have shown that various SERCA isoforms are inactivated upon
interaction with Bcl-2 [34, 35], which can be inhibited by HSP70 [36].
Here, we provide a comprehensive analysis of the expression profiles of Bcl-2 family
proteins for different types of cells trough different stages of myogenesis in the C2C12 cell
model, and determine the sensitivity of these cells to apoptosis. Currently, there are no
available data on Bcl-2 family protein expression specifically in myotubes and reserve cells,
and on the role of Bcl-2 family proteins in the apoptosis of differentiating C2C12 cells. The
only studies related to this matter demonstrated differential immunostaining of pro-apoptotic
members of the Bcl-2 protein family (i.e., Bad, Bak and Bax) in mononuclear and
multinuclear cells in the C2C12 model and in mouse primary myogenic cell culture, where
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Bcl-2 expression is limited to mononuclear, myogenin-negative cells and Bad, Bak, Bax and
Bcl-x are expressed in all myogenic cells [37, 38].
We analyzed the differential expression of proteins that can interact with Bcl-2 to control
apoptosis through different mechanisms in different muscle cell populations. We focused on
the expression levels of the proapoptotic proteins Bax, Bak and Bad and also of SERCA2B
and HSP70. We will show that reserve cells express higher levels of Bcl-2 and Hsp70
compared to myotubes, that correlate with their survival during the exposure to pro-
apoptotic stimuli, while myotubes, characterized by low levels of Bcl-2 and HSP70, exhibit
enhanced sensitivity to apoptosis. The increased apoptotic response of myotubes did not
correlate with the levels of the pro-apoptotic proteins Bax, Bak and Bad. Treatment of
differentiated C2C12 cells with hydrogen peroxide, a common pro-apoptotic agent, resulted
in the preferential loss of myotubes with low levels of Bcl-2, while myotubes with elevated
Bcl-2 levels were less sensitive to apoptosis. The overexpression of Bcl-2 in myoblasts prior
to differentiation, that resulted in an increase of Bcl-2 expression levels in myotubes,
partially protected myotubes from apoptosis. Our results suggest a role of Bcl-2 and
potentially HSP70 in the regulation of apoptotic responses in differentiated C2C12 cells and
lower importance of the pro-apoptotic proteins Bax, Bak and Bad.
MATERIALS AND METHODS
Cell Culture and incubations
C2C12 mouse skeletal muscle cells were obtained from the American Type Culture
Collection (ATCC, Rockville, MD). C2C12 myoblasts cells were cultured in growing
medium (GM) (DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum (FBS) and penicillin/streptomycin (Invitrogen)) at 37°C and 5% CO2 in a humidified
chamber. Myogenic differentiation was induced on confluent cultured cells by changing the
growth medium to differentiation medium (DM), supplemented with 2% horse serum
instead of FBS. DM was replaced every 2 days; the aspirated medium was collected and the
detached cells were recovered by centrifugation at 3000 × g for 5 min as described
elsewhere [15, 16]. Differentiated C2C12 cells were treated with H2O2 (Sigma), or
thapsigargin (TG) (Sigma) diluted in DMEM. In these experiments, cells were additionally
rinsed with DMEM to remove any detached cells before the addition of either H2O2- or TG-
containing media. For controls, cells were incubated in the same volume of DMEM without
additives. At certain time points the incubation media were recovered from the dish and the
detached cells collected by centrifugation as described above. The adherent cells were rinsed
with PBS and harvested in a small volume of PBS.
For WB analysis, the adherent and the detached cells were washed twice with PBS and
solubilized in a lysis buffer (20 mm Tris, pH 8, 150 mm NaCl, 1% Triton X-100, 10 mm
orthovanadate, 10 mm EDTA, 2 mm phenylmethylsulfonyl fluoride (PMSF), 1 mM
dithiothreitol (DTT), 1× protease inhibitor mixture) and then briefly sonicated and incubated
at 4 °C for 30 min. The protease inhibitor mixture (Complete, Mini) was from Roche
Applied Science (Indianapolis, IN). Afterwards, the cell lysates were centrifuged at 12,000 ×
g for 10 min at 4°C to remove cellular debris. Protein concentration of each freshly prepared
cell lysate was determined with Coomassie Blue Plus protein reagent (Pierce, Rockford, IL,
USA).
Isolation of Reserve Cells and Myotubes
After incubation in the differentiation medium, C2C12 cultures were separated into reserve
cells and myotubes by a differential trypsinization procedure [39]. Briefly, the myotubes
were specifically detached by mild trypsinization (incubation for 3 min in PBS containing
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0.025% (w/v) trypsin and 0.1 mM EDTA followed by the addition of excess GM), whereas
the reserve cells remained adherent to the dish. These cells were then detached by incubation
with higher trypsin concentrations (0.25% (w/v) trypsin and 1 mM EDTA) and reseeded
onto a dish in GM. After 30 min of incubation, the reserve cells attached to the culture dish
were harvested by scraping off into a small volume of PBS.
Cell imaging
Morphological changes and survival of cells were monitored under an inverted phase
contrast microscope (Olympus America Inc., Melville, NY) equipped with a digital camera
to obtain photomicrographs, and captured at ×20 initial magnification. For analysis of
morphological changes, cell images at different days of differentiation were processed using
the ImageJ program located in public domain of the National Institute of Health. To
demonstrate a shape of small myoblasts in GM, the images were zoomed in, while to show
the formation of long myotubes in DM, the images were zoomed out.
SDS-PAGE and Western Blot analyses
After treatment with 4× SDS loading buffer, proteins extracted from cells were separated on
precast Bio-Rad 4-20% gradient gels using tris-glycine running and sample buffers
(Invitrogen, Carlsbad, CA). The gels were then electro-blotted onto a PVDF membrane
(Millipore, Billerica, MA) prior to Western blot (WB) analysis. The spots were visualized
with the ECL or ECL-Plus detection kit (Amersham Biosciences, Piscataway, NJ) according
to the manufacturer's procedure. Rabbit anti-HSP70 polyclonal antibody (SPA-812) was
from Stressgen Biotechnologies (Ann Arbor, MI). Mouse monoclonal anti-Bcl-2 (sc-7382),
anti-Bax (sc-7480), anti-myogenin (sc-12732), anti-β-actin (sc-81178) and rabbit polyclonal
anti-Bak (sc7873), anti-Bad (sc-942), anti-MyoD (sc-304x) antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-SERCA2 (MAS-913)
and mouse monoclonal anti-SERCA1 (MA3-912) antibodies were from Stressgen
Biotechnologies (Ann Arbor, MI). Rabbit polyclonal anti-SERCA2B antibody was
generously provided by Drs. J. Enouf and R. Bobe (Inserm, Hopital Lariboisiere, Paris,
France) [40]. Polyclonal anti-caveolin 1 (610059) and mouse monoclonal anti-caveolin 3
(610421) were from BD Biosciences (San Jose, CA). Rabbit polyclonal anti-caspase 12
(2202) and mouse monoclonal anti-caspase 9 (9504) were from Cell signaling Technology
Inc. (Danvers, MA). Secondary horseradish peroxidase (HRP)-conjugated anti-rabbit
antibodies were from Sigma (St. Louis, MO), and HRP-conjugated anti-mouse antibodies
were from Pierce Biotechnology (Rockford, IL). The monoclonal anti-Pax7 antibody was
obtained from the Developmental Studies Hybridoma Bank, developed by Dr. David R. Sell
under the auspices of the National Institute of Child Health & Human development
(NICHD) and maintained by The University of Iowa, Department of Biology (Iowa City,
IA).
Mass spectrometry analysis
Aliquots of cell lysate containing 100 μg protein, reductively alkylated with 2 mM DTT and
5 mM iodoacetic acid, were precipitated by ethanol, reconstituted in 50 mM ammonium
bicarbonate, pH 7.8, and digested overnight with trypsin (sequencing grade from Promega,
Madison,WI) at a ratio to protein of 1:20. The resulting peptide samples were introduced
into an LTQ-FT hybrid linear quadrupole ion-trap FT-ICR (Fourier-transform ion cyclotron
resonance) mass spectrometer (Thermo Finnigan, West Palm Beach, FL) via capillary LC
using a nanoAcquity UPLC (Waters Corp., Milford, MA). Peptides were separated on a
reverse-phase C18 column (Acclaim PepMap300, 300 Å, 5 μm, 15 cm ×300μm
I.D.,Thermo, West Palm Beach, FL). A linear gradient was developed from 1 to 40% B in
100 minutes, ramped to 95% B in 8 minutes and held at 95%B for 10 minutes at a flow rate
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of 10 μL/min with solvents A (99.9% H2O, 0.1% formic acid) and B (99.9% acetonitrile,
0.1% formic acid). The nanoAquity UPLC Console (Waters Corp., version 1.3) was used to
execute the injections and gradients. The ESI source was operated with a spray voltage of
2.8 kV, a tube lens offset of 160 V and a capillary temperature of 200°C. All other source
parameters were optimized for maximum sensitivity of the YGGFL peptide MH+ ion at m/z
556.27. The instrument was calibrated using an automatic routine based on a standard
calibration solution containing caffeine, the peptide MRFA and Ultramark 1621 (Sigma).
A data-dependent acquisition method for the mass spectrometer (configured version LTQ-
FT 2.2) was set up using the Xcalibur software (ThermoElectron Corp., San Jose, CA,
version 2.0). Full MS survey scans were acquired at a resolution of 50,000 with an
Automatic Gain Control (AGC) target of 5×105. The five most abundant ions were
fragmented in the linear ion trap by collision-induced dissociation with AGC target of 2×103
or maximum ion time of 300 ms. The ion selection threshold was 500 counts. The LTQ-FT
scan sequence was adapted from a published procedure [41].
For protein identification, MS/MS spectra were analyzed using Mascot (Matrix Science,
London, UK; version 2.3) and Sequest (Proteome Discoverer, Thermo Fisher Scientific, San
Jose, CA, version 1.3) search engines. The programs were set up to search the Uniprot-sprot
and IPI (mouse) databases assuming the digestion enzyme trypsin. Mass tolerances for
precursor and fragment ions were 20 ppm and 0.20 amu respectively, and
carboxymethylation of cysteine residues was considered as a fixed modification. The
Sequest and Mascot results then were imported into a Scaffold program (Proteome
Software; version 3.4) for analyzing with the X!Tandem search algorithm (the GPM,
thegpm.org; version 2010.12.01.1) and statistical validation of peptide and protein identities.
Peptide and protein identifications were accepted if they could be established at greater than
95% probability. Relative quantification of the proteins was achieved using the spectrum
counting method [42, 43] and the MS/MS total ion current (TIC) values using the Scaffold
reports.
RESULTS
Myogenic differentiation of C2C12 cells
Six days after the onset of C2C12 myoblast differentiation they undergo cell fusion and
form multinuclear myotubes (Fig. 1a). This morphological change is accompanied by a
gradual increase in expression levels (detected by WB) of muscle-specific proteins such as
myogenin, a transcription factor of late stage myogenesis, and SERCA1, the fast-twitch
muscle-specific isoform, which can serve as a protein marker of mature myotube formation
(Fig.1b). Another muscle-specific protein isoform, caveolin-3 (Cav3), is expressed only
during late stage of differentiation, while the ubiquitous caveolin-1 (Cav1) isoform was
detected already in myoblasts (i.e., at day 0) with a gradual increase in expression levels
during differentiation (Fig.1b).
Next we used WB analysis to study protein expression profiles separately in myotubes and
reserve cell subpopulations, fractionated based on their differential sensitivity to trypsin [39,
44]. As expected, myogenin, SERCA1 and Cav-3 were detected in the fraction of terminally
differentiated myotubes, in contrast to original myoblasts. Importantly, in the reserve cell
fraction of differentiated C2C12 cells none of these proteins were observed, suggesting a
high purity of the fractionated cell populations (Fig. 1c). Cav1 expression levels were higher
in reserve cells than in myoblasts or myotubes, in good agreement with previously published
data on the expression of Cav1 in reserve cells [45].
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Expression of apoptosis regulator proteins during myogenic differentiation of C2C12
myoblast cells
With regard to a potential regulatory effect on apoptosis accompanying C2C12 cell
differentiation, we analyzed the expression levels of the anti-apoptotic protein Bcl-2, Hsp70,
and of the pro-apoptotic proteins of the Bcl-2 family, Bax, Bak and Bad. We did not detect
significant changes in the expression levels for these proteins during C2C12 cell
differentiation (Fig. 2a); similar results were previously reported [38]. Note that an apparent
increase in the Bcl-2 levels for cells incubated in DM (i.e., starting from day 2) relative to
myoblasts (incubated in DMEM) is due to non-specific recognition of immunoglobulins,
present in the horse serum supplement of DM, by the secondary antibodies used for WB
detection (data for respective controls are not shown).
Differences became apparent when these proteins were monitored individually for myotubes
and reserve cells (Fig. 2b). The two important protein markers to control the purity of the
reserve cell fractions, Pax7 and MyoD (a marker of activated myoblasts), were also
monitored. Reserve cells express both Pax7 and MyoD, in contrast to isolated myotubes
where neither Pax7 nor MyoD were detected (Fig. 2b). Importantly, Bcl-2 was expressed
predominantly in the reserve cell fractions (Fig. 2b), where Bcl-2 levels were significantly
higher than in non-differentiated myoblasts. The dramatic difference in Bcl-2 levels between
myotubes and reserve cells (Fig. 2c), given that Bcl-2 is co-expressed with Pax7 and Cav1
(Fig. 1c), makes Bcl-2 a useful marker for reserve cells in differentiating C2C12 cells. WB
analysis of HSP70 showed a moderate increase of HSP70 expression levels in reserve cells
and a significantly lower expression in myotubes. The pro-apoptotic proteins Bax, Bak, and
Bad did not exhibit a pronounced difference in the expression levels between myotubes and
reserve cells, with a slight prevalence in reserve cells versus myotubes. Our data for Bcl-2
expression in reserve cells and myoblast cells, as well as the expression pattern of pro-
apoptotic proteins in these cell types are in a good agreement with previous immunostaining
studies [37, 38]. Thus, the most significant difference between the differentiated C2C12 cell
fractions is a specifically lower expression of HSP70 and Bcl-2 in myotubes relative to
reserve cells.
Expression of SERCA2A and SERCA2B during myogenic differentiation of C2C12
myoblast cells
We monitored SERCA2 expression levels during C2C12 cell differentiation by WB analysis
with the help of commercially available anti-SERCA2 antibodies. These antibodies
recognize two isoforms, SERCA2B, a “house-keeping” isoform expressed ubiquitously, and
SERCA2A, the isoform specific for cardiac and slow-twitch muscle. Both isoforms have
identical sequences except for the C-terminal part (Fig. 3a), where SERCA2B contains a 50-
amino acid stretch,
GKECVQPATKSSCSLSACTDGISWPFVLLIMPLVVWVYSTDTNFSDMFWS, and
SERCA2A, instead, a short sequence, AILE [46]. The SERCA2 isoform expressed before
differentiation onset (day 0) is most likely SERCA2B (see also below). During
differentiation of C2C12 cells, a significant increase in SERCA2 levels is observed (Fig.3b),
increasing 2-fold by day 6 incubation in DM (Fig.3c). To reveal which isoform of SERCA2
is upregulated during differentiation, we used anti-SERCA2 antibodies recognizing both
isoforms, and a custom-made antibody raised against the C-terminal peptide of SERCA2B
(underlined in Fig. 3a), generously provided to us by Drs. J. Enouf and R. Bobe (Inserm,
Hospital Lariboisiere, Paris, France). WB analysis with a non-isoform-specific antibody
against SERCA2 revealed a significant difference in the expression levels of SERCA2
between myotubes and reserve cells: while the terminally differentiated myotubes expressed
very high levels of SERCA2, the reserve cells showed little differences compared to original
myoblast cells (Fig.3d). In contrast, the anti-SERCA2B antibody did not reveal significant
Schoneich et al. Page 6













changes in the levels of SERCA2B between myoblasts, myotubes and reserve cells at
different stages of differentiation (Fig. 3d). Therefore, the data obtained with the non-
specific SERCA2 antibodies can be attributed solely to the increase in expression of the
SERCA2A isoform in myotubes during differentiation.
Additional evidence for the high expression level of the SERCA2A isoform in myotubes
was obtained through the use of proteomic analysis based on the mass spectrometry
identification of isoform-specific peptides from the C-terminal sequences of SERCA2A and
SERCA2B. The SERCA2A-specific C-terminal tryptic peptide (R)NYLEQPAILE was
identified (Fig. 3e), suggesting that the SERCA2A isoform is expressed in C2C12 myotubes,
in agreement with the data of transcriptomic analysis performed in developing muscle tissue
and C2C12 cells [47, 48]. However, no tryptic peptides from the C-terminal region of
SERCA2B were observed in any sample (including original myoblasts) suggesting a low
abundance of this isoform relative to SERCA2A in myotubes.
Role of Bcl-2 and HSP70 in apoptosis accompanying myogenic differentiation of C2C12
myoblast cells
To further determine the role of Bcl-2 family proteins and HSP70 in myogenic
differentiation and apoptosis of differentiating C2C12 cells we characterized their
expression levels specifically in cells undergoing apoptosis, i.e. detached (floating) cells,
versus live adherent cells. The detached cells forming during C2C12 cell differentiation
represent a small fraction compared to cells adherent to the dish. The relative quantification
of apoptotic cells on day 2, based on the amount of protein, show the development of
apoptosis during differentiation (Fig. 4a). For comparison, we collected the adherent cells
from the dishes at different days of differentiation. Fig. 4a shows that at the time of myotube
formation (day 6), the amount of detached cells is similar to that at the early stage of
differentiation (day 2), so the formation of mature myotubes does not prevent cells from
detachment. A slight loss of adherent cells from the dish was also observed at day 6 (Fig.4a).
To characterize the apoptotic process, we analyzed the activities of caspase 9 and caspase 12
during differentiation in both detached and adherent cells (Fig. 4b). The level of active
caspase 9 (lower band on WB) was significantly higher in detached floating cells than in the
adherent cells, in agreement with previously published results [15]. The highest levels of
active caspase 12 (lower band on WB), an ER stress-specific caspase, in the attached cells
were observed on day 2 of differentiation (Fig. 4b), while the highest protein levels of
caspase 12 in the detached cells were observed at late stage of differentiation (day 6). Since
the detached cells cannot be physically separated into myotubes and reserve cells, unlike the
attached cells, we monitored the expression levels of myotube markers, such as SERCA1
and Cav-3, in the detached cells. Fig. 4b demonstrates that the myotube marker SERCA1
displayed higher levels in detached cells compared to the adherent cells, reflecting a
predominant sensitivity of myotubes to apoptosis accompanying myogenic differentiation of
C2C12 cells. The time-course of SERCA2 expression in both adherent and apoptotic
detached cells was similar to that of SERCA1, corresponding to the accumulation of
predominantly the SERC2A isoform in differentiated myotubes (see above). Of note, we
detected intense higher molecular weight bands of SERCA1 and SERCA2 (data not shown),
indicative of aggregation in the floating cells, which can be rationalized by the high
sensitivity of SERCA Cys residues to oxidation [49]. It is unclear why the levels of Cav-3
were similar in detached and adherent cells. Considering that adherent cells represent a
mixture of myotubes and reserve cells, we suggest that apoptotic myotubes detached from
the dish may have lower levels of Cav-3 compared to myotubes adherent to the dish. Such
feature could reveal a yet uncharacterized role of Cav-3 for the adhesion of myotubes to the
dish during differentiation.
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WB analysis of Bcl-2 and HSP70 shows diminished levels of these proteins in the apoptotic
detached cells as compared to the adherent cells for all times after the onset of
differentiation (Fig. 4c). Again, the detached apoptotic cells display the features of myotubes
(compare with Fig. 2b), corroborated by the lack of both a reserve cell marker, Pax7, and a
marker of activated myoblast, MyoD, in the detached cells over the entire differentiation
period (Fig. 4c). Based on these results we conclude that the cells specifically sensitive to
apoptosis during differentiation are neither myoblasts nor reserve cells; rather, they
represent mature myotubes or myotubes at the early stages of transformation, characterized
by low levels of Bcl-2 and HSP70 expression.
The assessment of pro-apoptotic proteins Bax, Bak, and Bad in the detached cells at the late
stage of differentiation (day 6) reveals no increase in the protein expression levels; however,
an additional lower molecular weight band appears, which is not present in the adherent
cells and may represent a nonphosphorylated form of these proteins (more distinctive for
Bax) (Fig. 4d). The main band (likely the phosphorylated form of Bax) is slightly larger in
the adherent cells relative to the detached cells. The levels of Bak and Bad expression in the
adherent cells were much higher than in the floating cells following the elevated levels of
these proteins in the reserve cells (Fig. 4b), a subpopulation that is more resistant to
apoptosis and adheres to the dish. Thus, these results suggest no significant contribution of
pro-apoptotic Bax, Bad and Bak proteins to the sensitivity of C2C12 cells to apoptosis
during differentiation.
An important question is whether our observations apply to apoptosis in general, or whether
they are specific for apoptosis accompanying C2C12 cell differentiation. Therefore, for
comparison, we investigated the sensitivity of differentiated C2C12 cells to H2O2, i.e.
oxidative stress-induced apoptosis. These results are described in the following.
Apoptotic sensitivity of myotubes and reserve cell subpopulation of differentiated C2C12
cells to H2O2
Recent work demonstrated that the incubation of differentiated C2C12 cells with as high as
4 mM H2O2 for 24 h led to apoptosis, although no data on which specific cells undergo
apoptosis have been provided [20]. Therefore, we explored the differential sensitivity of
myotubes and reserve cells to hydrogen peroxide-induced apoptosis. The microscopic
images in Fig. 5 show the H2O2 concentration-dependent loss of myotubes through
detachment upon the treatment of differentiated C2C12 cells with increasing concentrations
of H2O2. We note that cells detach after 4 h incubation with as low as 0.5 mM H2O2 and at
4 mM H2O2 virtually no myotubes remain attached. For the maximal concentration of H2O2
tested this effect is observed even for lower incubation times (Fig.5f).
WB analysis of the cells remaining on the dishes after incubation with 4 mM of H2O2 (Fig.
6a) discloses a marked time-dependent decrease in the levels of myotube markers, SERCA1
and Cav3. In contrast, Bcl-2 levels slightly increase, suggesting an increase of the fraction of
reserve cells in the adherent cells (Fig.6a). Therefore, H2O2 produces a selective loss of
myotubes in a time- and concentration-dependent manner. An increase in the incubation
time allows to detect the pro-apoptotic effects of H2O2 on myotubes at physiologically more
relevant H2O2 concentrations such as 200 μM based on the levels of SERCA1, Cav1 and
Bcl-2 (Fig.6b); in the same time, the amounts of reserve cells do not significantly change or
even increase slightly. The latter effect is due to significantly higher fractions of the reserve
cells in the total mass of differentiated C2C12 cells. This can be easily demonstrated by a
comparison of SERCA1 and Bcl-2 levels in both adherent and detached cells after H2O2
treatment (Fig. 6c).
Schoneich et al. Page 8













Proteomic analysis of apoptotic cells: different stimuli result in different myotube-specific
protein profiles
In addition to WB detection of selected cell-specific protein markers, we performed a WB
analysis of the proteins of the detached cells obtained upon treatment for 4 h with 4 mM
H2O2. To validate our approach, the detached cells were also produced by the incubation
with 1 μM TG, an ER stress and apoptosis inducer, and by mild trypsinization to obtain a
pure fraction of myotubes. The myotube content in these samples was monitored through the
analysis of the cell-specific protein markers as shown in Fig.7a. The levels of Cav3, a
marker of mature myotubes, were similar for apoptotic cells after H2O2 treatment and
myotubes isolated by mild trypsinization. In contrast, apoptotic cells obtained by TG
treatment showed lower levels of Cav3 and higher levels of Bcl-2. Thus, the detached cells
obtained by TG-induced apoptosis demonstrated less similarity to the control myotubes, and
represent a mixture of myotubes and reserve cells.
These findings were further confirmed by proteomic analysis and relative quantification of
muscle-specific proteins by TIC (identified by specific MS/MS analysis) during shotgun
LTQ-FT-MS/MS analysis of respective protein digests [42, 43] as described under
“Experimental Procedures”. We quantified the TIC values of peptides representing
SERCA1, SERCA2, myosin light chain, myosin 3 and troponin T (skeletal muscle fiber-
specific protein isoforms) as well as β-tubulin and myosin-9, the non-specific isoforms (Fig.
7B). Generally the levels of muscle-specific proteins (SERCA1, SERCA2, myosin light
chain, myosin 3 and troponin T) are similar for H2O2-induced apoptotic cells and control
myotubes, in contrast to TG–induced apoptotic cells. The latter show different, significantly
less myotube-specific protein profiles. These data validate the applicability of the proteomic
approach for the identification of myotubes as a selective target for H2O2-induced apoptotis
in differentiated C2C12 cells.
Protection of myotubes by Bcl-2 against H2O2-induced apoptosis
Although the expression level of Bcl-2 in reserve cells is much higher than in myotubes,
Bcl-2 is also expressed in myotubes at low levels. To study the impact of these low
expression levels of Bcl-2 on the sensitivity of myotubes to H2O2-induced apoptosis we
analyzed the adherent myotube cells surviving H2O2 treatment (Fig.8a). We separated the
subpopulations of respective myotubes and reserve cells by mild trypsinization as described
above under control of cell-specific protein markers. Fig. 8b shows that the expression levels
of Bcl-2 in the population of myotubes resistant to H2O2-induced apoptosis are much higher
than those in control myotubes, based on representative average Bcl-2 levels for the entire
myotube population. The densitometry quantification of the Bcl-2 protein levels for H2O2-
resistant and average myotubes is presented in Fig.8c. H2O2-resistant myotubes also exhibit
lower levels of SERCA1 and Cav3 expression, suggesting that they may represent a
subpopulation of less mature myotubes, i.e. myotubes at less advanced stage of
differentiation.
To test whether higher levels of Bcl-2 expression in myotubes increase their tolerance to
H2O2-induced apoptosis, we analyzed the effect of Bcl-2 overexpression. Proliferating
C2C12 cells (myoblasts) were transfected with a Bcl-2 expression vector and differentiation
was initiated 24 h after transfection. First we looked at the effect of Bcl-2 on apoptosis
during differentiation. The WB analysis of selected proteins in apoptotic (detached) cells
collected at different days of differentiation is shown in Fig. 9a. Bcl-2 overexpression
resulted in high levels of the protein in the detached cells collected at days 2 and 4 after the
onset of differentiation, when the highest rate of apoptotic death is observed (compare to
Fig. 3A), suggesting that Bcl-2 overexpression does not protect these cells from apoptosis
accompanying C2C12 cell differentiation. Higher levels of Bcl-2 present in the detached
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cells at late stage of differentiation (day 6) also failed to protect these mature myotubes from
spontaneous apoptosis (Fig.9a). Importantly, analysis of Bcl-2 expression in myotubes and
reserve cells (Fig.9b) confirmed that the myotubes rather than the reserve cells contained
significantly elevated levels of Bcl-2 after overexpression. Of note, overexpression of Bcl-2
also resulted in increased levels of pro-apoptotic Bax (both phosporylated and no-
phosphorylated forms) in the myotubes, without significant changes in the levels of other
pro-apoptotic proteins, Bak and Bad (data not presented).
We further analyzed the effect of Bcl-2 overexpression on the survival of myotubes after
H2O2-induced apoptosis. In serum-free media without added H2O2, lower levels of Cav3
indicate a reduced number of attached myotubes, i.e., an increased apoptotic death due to
serum withdrawal in Bcl-2 overexpressing cells (Fig. 9c, lanes 1 and 2). However, sham
transfected cells displayed significantly less tolerance to H2O2-induced apoptosis based on
the Cav3 levels in both the attached and the detached cells (compare lanes 3 and 4, 5 and 6,
respectively, in Fig. 9c). WB densitometry quantitation data are presented in Fig. 9D
showing a ca. 40% protection of myotubes overexpressing Bcl-2 against H2O2-induced
apoptosis. Bcl-2 protection occurred despite the higher levels of activaved caspase 9
detected in detached cells (Fig. 9c) potentially due to higher levels of Bax (Fig. 9b) in the
Bcl-2 overexpressing myotubes. Taken together, our data reveal a protective effect of Bcl-2
against H2O2-induced apoptosis in myotubes but not against apoptosis accompanying
myocyte differentiation.
DISCUSSION
The differentiation of skeletal muscle satellite cells represents a complex multi-step process
and apoptosis is one of the routes accompanying differentiation [3, 13, 50, 51]. In the current
work, we studied the expression profiles of Bcl-2 and pro-apoptotic Bax, Bak and Bad and
also of SERCA2B and HSP70, proteins that can interact with Bcl-2 and control apoptosis in
different steps of differentiation through diverse mechanism. We performed analysis of
protein expression profiles separately for reserve cells, myoblast and myotubes at different
stages of C2C12 cell differentiation and correlated them with apoptotic responses of these
cell populations. The formation of two distinct cell populations at the late stages of
differentiation (day 6) with different morphology, sensitivity to trypsin, and protein markers
of reserve cells (Pax7 and Cav1) and myotubes (myogenin, SERCA1 and Cav3) makes their
separate characterization a feasible task. WB analysis allows for detection of very low
expression levels of Bcl-2 in myotubes, in contrast to the high expression levels of Bcl-2 in
the reserve cells (Fig. 2b), that is in good agreement with previous immunostaining studies
[37, 38]. In addition, reserve cells express higher levels of Hsp70 and proapoptotic proteins
Bax and Bak compared to myotubes (Fig. 2b). We also show that Bcl-2 can be barely
detected in myoblasts. Such feature of the reserve cells turns Bcl-2, together with Pax7 and
Cav1, into a very useful marker of reserve cell subpopulations during muscle cell
differentiation. The activation of reserve cells may induce them to re-enter the cell cycle for
transformation to proliferating myoblasts with low Bcl-2 expression, which is a necessary
step prior to the formation of myotubes (to replace damaged myotubes) with lowest levels of
Bcl-2, and generate a new reserve cell population with high Bcl-2 expression. Since the
contribution of different cell fractions may vary over time under different conditions, the
knowledge of the expression profile of Bcl-2 in different cells through myogenic
differentiation can be helpful for analysis of the effect on myogenic differentiation, and
could help to avoid data misinterpretation.
Our data, in accord with earlier publications [12-15], demonstrate spontaneous apoptosis of
activated myoblasts at the early stage of differentiation, accompanied by the detachment of
apoptotic cells from the culture dish. In contrast, based on the expression of myotube
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markers, SERCA1 and Cav3, and on Bcl-2 for reserve cells, we now show that at a late
stage of C2C12 cell differentiation, myotubes are specifically sensitive to spontaneous
apoptosis leading to the detachment and loss of myotubes (Fig.4). We show higher
expression levels of Bcl-2 in reserve cells then in myoblasts (Fig. 2b), whereas myoblast
cells display higher expression levels of pro-apoptotic proteins, Bax, Bak and Bad, and
therefore even higher ratios of pro-apoptotic to anti-apoptotic proteins compared to reserve
cells. This is consistent with earlier published data on the high sensitivity of myoblasts to
apoptotic signals [8], and likely represents a common mechanism of apoptotic regulation
based on the interaction between pro- and anti-apoptotic Bcl-2 family members [22].
An important question is what could be a reason for the down-regulation of Bcl-2 when
activated reserve cells transform to myoblasts? In our study, the expression of MyoD, a
transcription factor implicated in the early stage of myogenic differentiation and necessary
for the progression of quiescent muscle satellite cells in the cell cycle [50, 52, 53], was
detected primarily in C2C12 myoblasts; reserve cells showed significantly lower expression
levels, and myotubes contained only trace amounts of MyoD (Fig.2b). The levels of MyoD
inversely correlate with the levels of Bcl-2 in myoblast and reserve cells (Fig.2b), and the
higher sensitivity of myoblasts to apoptosis upon activation of differentiation shown by us
and other studies [54]. It was suggested before that MyoD, in addition to the regulation of
differentiation [55, 56], may control apoptosis, and a pro-apoptotic role of MyoD was
credited to Pax3 and the miRNA-1 and miRNA-206-mediated down-regulation of Bcl-2 and
Bcl-xL [54,57]. Though, further studies on the regulation of Bcl-2 levels specifically in
different subpopulations of differentiating C2C12 cells through MyoD and other potential
mechanisms will be needed.
However, the underlying mechanism of apoptotic sensitivity of myotubes at a late stage of
differentiation (day 6) is apparently dissimilar to mechanisms of apoptosis at early stage of
differentiation discussed above. In apoptotic floating myotubes we failed to detect increased
levels of Bak and Bad, although Bax exhibited an additional low molecular band in the
detached cells, probably corresponding to a non-phospohorylated form (Fig.4d). We also
detected a similar de-phosphorylated form of Cav1 in the detached cells (data not shown),
which can potentially be rationalized by a general decrease of kinase relative to phosphatase
activity in the apoptotic cells. Thus, our results suggest that apoptotic detachment of
myotubes during differentiation is not likely regulated by pro-apoptotic proteins of the Bcl-2
family alone. In addition to Bcl-2, the resistance of reserve cells to apoptosis accompanying
muscle cell differentiation may also be credited to the higher levels of HSP70 in the
adherent cells (Fig.4c).
Recently, it was reported that Bcl-2 and HSP70 may interact with the sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA2B) in C2C12 myoblasts [36]; specifically in vitro
experiments demonstrated a strong effect of Bcl-2 on SERCA activity [34, 35], suggesting
that both Ca2+ homeostasis, and, therefore, apoptosis in muscle cells might be affected by
such interactions. A key observation of the present study is the difference in the expression
levels of Bcl-2 and Hsp70 between differentiated C2C12 reserve cells and myotubes while
the expression of SERCA2B remained at comparable levels (Fig.3c). It is possible that the
low expression levels of Bcl-2 and HSP70 in myotubes result in higher SERCA2B activity
and higher ER Ca2+ levels available for the execution of apoptosis. Unfortunately, we were
unable to measure the specific activity of SERCA2B in myotubes because of the high
expression levels of other SERCA isoforms involved in the muscle contraction and
relaxation cycle, SERCA1 and SERCA2A. It is tempting to hypothesize that Bcl-2 and
HSP70 may work as putative modulators of SERCA2B and Ca2+-regulated apoptosis in
myotubes depicted in the scheme in Fig.10. Besides, other potential mechanisms, which
could control Ca2+ homeostasis and Ca2+-dependent apoptosis, such as changes in the
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expression levels of inositol triphosphate receptor (IP3R), previously revealed in model
systems and in dystrophic myotubes [26, 32], and the interaction of Bcl-2 with the IP3R [58]
have also to be also considered.
Spontaneous apoptosis of mature (differentiated) C2C12 induced by hydrogen peroxide cells
was chosen as a comparative model to study apoptotic responses in different cell types.
Hydrogen peroxide-induced apoptosis of differentiated C2C12 cells has been described [20];
however, in previous studies no analysis of isolated populations of differentiated cells
(reserve cells and myotubes), as well as of adherent and non-adherent cells have been
performed. Here, by monitoring the myotube markers SERCA1 and Cav3 and a marker of
the reserve cells, Bcl-2, for both adherent and detached cells, we found that H2O2-induced
apoptotic detachment involves primarily mature myotubes (Figs. 5 and 6). Proteomic
analysis of apoptotic (detached) cells after exposure to hydrogen peroxide confirmed the
similarity of muscle-specific protein expression profiles of these cells to control myotubes,
fractionated by mild trypsinization. In contrast, the apoptotic cells produced by treatment
with TG, a specific SERCA inhibitor, represent a mixture of myotubes and reserve cells.
The overexpression of Bcl-2 in myoblasts prior to differentiation resulted in higher levels of
Bcl-2 expression in the myotubes whereas those in the reserve cells were not significantly
altered (Fig. 9b). Importantly, the higher levels of Bcl-2 in these myotubes correlated with
an elevated resistance to H2O2-induced apoptosis (Fig. 9c and 9d). In contrast, Bcl-2
overexpression did not prevent spontaneous apoptosis of myoblasts at early stages of
differentiation (Fig. 9a). These data suggest different control mechanisms for early stages of
differentiation and hydrogen peroxide-induced apoptosis. However, one cannot exclude that
Bcl-2 overexpression may result in some as yet unidentified changes in cell adhesion and/or
myotube formation, suggesting an additional role of Bcl-2 in differentiation besides
protection against apoptosis.
Taken together, our results demonstrate that apoptotic responses in differentiated C2C12
cells are likely regulated through expression of Bcl-2 so that the sensitivity of myotubes and
the resistance of reserve cells to apoptosis result from low and high Bcl-2 levels,
respectively. The downstream mechanism(s) for terminally differentiated cells may involve
pro-apoptotic Bcl-2 family members, such as Bax, Bak, and Bad, which may contribute to
spontaneous apoptosis during muscle cell differentiation; in addition, proteins implicated in
regulation of Ca2+-mediated apoptosis, such as SERCA2b and HSP70, may be involved.
Further studies are necessary to prove the physiological relevance of under normal and
pathological conditions.
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Fig.1. Differentiation of C2C12 myoblasts and myotube formation
(a) – Phase contrast light microscopy of proliferating myoblasts and myotubes formed on
day 6 of differentiation. (b) - WB analysis of specific protein marker expression during
C2C12 cell differentiation assessed with antibodies against myogenin, SERCA1, Cav3, and
Cav1. Actin expression levels are shown as controls for protein load. (c) – Myotubes and
reserve cells were separated at days 4 (4d) and 6 (6d) of differentiation, as shown in the
schematic representation and described under “Experimental Procedures”, and analyzed by
WB with antibodies specific for myogenin, SERCA1, Cav3, and Cav1. The abbreviations
used for the cell types are M - proliferating myoblasts; T – myotubes; R - reserve cells.
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Fig.2. Expression profiles of Hsp70 and Bcl-2 family proteins during myogenic differentiation of
C2C12 cells
(a) - Proliferating myoblasts (day 0) and differentiating C2C12 cells were harvested on days
2 - 6 after the onset of differentiation and analyzed by SDS-PAGE and WB analysis with
antibodies against Hsp70, Bcl-2, Bax, Bak, and Bad. (b) – Analysis of these proteins
separately in myoblasts (M), myotubes (T) and reserve cells (R) along with cell type-
specific protein markers Pax7 and MyoD at days 4 (4d) and day 6 (6d) of differentiation. (c)
Densitometry analysis of data from (b).
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Fig.3. Expression of SERCA2A and SERCA2B isoforms in differentiating C2C12 cells
(a) – Sequence specificity of SERCA2A and SERCA2B in the C-terminal part. (b) – WB
analysis of protein expression during C2C12 cell differentiation assessed with antibodies
against SERCA2. (c) - Densitometry analysis of WB data of SERCA2 level in GM and in
DM after 6 days of differentiation from three independent experiments.(d) – Analysis of
SERCA2 isoforms separately in myoblasts (M), myotubes (T) and reserve cells (R):
myotubes and reserve cells were separated as described under “Experimental Procedures” at
day 6 of differentiation and analyzed by WB with antibodies specific for SERCA2 and
SERCA2B (polyclonal custom antibody raised against the C-terminal peptide underlined in
panel A). (e) - Capillary LC-LTQ-FT-MS/MS spectrum of the C-terminal tryptic peptide of
SERCA2A, identified in the tryptic digests of C2C12 cell lysates.
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Fig.4. Characterization of apoptotic proteins in the adherent and detached cells during C2C12
differentiation
(a) – Total protein content in harvested cells normalized to the value for adherent cells
harvested on day 2. (b) – WB analysis of adherent and detached cells with anti-caspase 9,
anti-caspase 12, anti-SERCA1, anti-cav3, and anti-SERCA2 antibodies. Actin expression
levels in cells are presented for control of protein load. (c) - WB analysis of adherent and
detached cells with anti-Bcl-2, anti-Hsp70, anti-Pax7 and anti-MyoD antibodies. (d) - WB
analysis of adherent (lane 1) and detached (lane 2) cells on day 6 of differentiation with anti-
Bax, anti-Bak and anti-Bad antibodies.
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Fig.5. Morphology of differentiated C2C12 cells after H2O2 treatment
Phase contrast light microscopy of differentiated C2C12 cells prior to (a) and after exposure
to 0.5 (b), 1 (c), 2 (d), and 4 mM H2O2 (e) for 4 h or 2 h (f) as described under
“Experimental Procedures”.
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Fig.6. WB analysis of protein markers in differentiated C2C12 cells adherent and detached from
the plate after exposure to hydrogen peroxide
Differentiated C2C12 cells were incubated without (control) or with 4 mM H2O2 for
different times as indicated (a) or incubated overnight with smaller concentrations of H2O2
(b), and adherent cells were analyzed by WB with anti-SERCA1, anti-Cav3 and anti-Bcl-2
antibodies. Actin expression levels are presented for control of protein load. (c)
Differentiated C2C12 cells were incubated in the absence or in the presence of 4 mM H2O2
for 4 h, and expression levels of SERCA1 and Bcl-2 were analyzed by WB separately for
adherent and detached cells.
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Fig.7. WB and MS analyses of selected proteins in detached cells collected after mild
trypsinization to obtain myotubes (T) or incubation of differentiated C2C12 cells with either 4
mM H2O2 or 1 μM thapsigargin (TG) for 4 h
(a) – Detached cells obtained after different treatment were harvested as depicted in the
inserted scheme and analyzed by WB for Cav3, Bcl-2, and actin. (b) – Differentiated C2C12
cells treated as above were lysed, digested with trypsin, and submitted to a “shotgun”
capLC-LTQ-FT-MS/MS analysis coupled to a protein database search, followed by a
quantification of peptide TIC values for selected proteins as described under “Experimental
Procedures”. Protein IDs in the IPI (mouse) database: SERCA1, 00311654; SERCA2,
00468900; Myosin light chain, skeletal muscle, 00224549; Myosin 3, 00380895; Myosin 9,
00123181; Troponin c, slow-twitch skeletal muscle, 00113712; Tubulin beta, 00117352.
(Note: error bars on logarithmic scale).
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Fig.8. Bcl-2 protects myotubes from H2O2-induced apoptosis
Differentiated C2C12 cells were incubated without (control) or in the presence of 4 mM of
H2O2 for 2 h as shown in the schematic representation, and myotubes and reserve cells were
separated by mild trypsinization as described under “Experimental Procedure”. (a) – Scheme
of experiment. (b) – Expression profiles of Bcl-2, SERCA1, Cav3, and Pax7 in myotubes
and reserve cells analyzed by WB after incubation without (control) or with 4 mM H2O2 for
2 h. (c) - Bcl-2 levels in non-treated myotubes (control) and myotubes remaining attached to
the dish after incubation with 4 mM H2O2 for 2 h, collected by mild trypsinization, and
analyzed by a densitometry analysis of the respective blots presented in panel B.
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Fig.9. Effect of overexpression of Bcl-2 on myotube apoptosis
Proliferating C2C12 myoblasts were transfected with either empty vector or Bcl-2
expression vector for 24 h before the onset of differentiation. (a) - Cells detached from the
dishes at days 2, 4, and 6 after the initiation of differentiation were harvested and analyzed
by WB for Bcl-2, SERCA1, Cav3 and caspase 9. (b) - Myotubes and reserve cells remaining
attached to the dishes at day 6 after initiation of differentiation were separated via
differential trypsinization as described under “Experimental Procedures”, and analyzed by
WB with anti-Bcl-2 and anti-Bax antibodies. (c) – Control and Bcl-2 transfected C2C12
cells at day 6 after initiation of differentiation were incubated without or with 4 mM H2O2
for 2 hours, followed by WB analysis for Cav3, Bcl-2, and caspase 9 of both adherent and
detached cells. (d) - Densitometry quantification of Cav-3 on the blots (marker of myotubes)
shown in panel C, normalized to the level of Cav-3 in Bcl-2 transfected cells, remaining
adherent to the dish after exposure to 4 mM H2O2 for 2 hours.
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The interplay between Bcl-2 family proteins and HSP70 to control apoptotic responses of
myotubes and reserve cells.
Schoneich et al. Page 25
Apoptosis. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
